Drug Design Development and Therapy

Scope & Guideline

Transforming Pharmaceutical Science with Cutting-Edge Insights

Introduction

Welcome to your portal for understanding Drug Design Development and Therapy, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1177-8881
PublisherDOVE MEDICAL PRESS LTD
Support Open AccessYes
CountryNew Zealand
TypeJournal
Convergefrom 2007 to 2024
AbbreviationDRUG DES DEV THER / Drug Des. Dev. Ther.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND

Aims and Scopes

The journal 'Drug Design Development and Therapy' focuses on advancing the field of drug development and therapeutic strategies through rigorous research that encompasses a variety of methodologies and disciplines.
  1. Drug Discovery and Development:
    The journal emphasizes original research articles that explore novel drug candidates, their mechanisms of action, and the methodologies involved in the drug development process.
  2. Pharmacology and Toxicology:
    Articles in this area assess the pharmacokinetics, pharmacodynamics, and toxicological profiles of various compounds, providing critical insights into their therapeutic potential.
  3. Clinical Applications and Trials:
    The journal publishes clinical studies, trials, and retrospective analyses that evaluate the efficacy and safety of drugs and treatment protocols in real-world settings.
  4. Integrative Approaches in Medicine:
    Research that combines traditional medicine with modern pharmacological techniques, particularly those utilizing network pharmacology and systems biology, is a significant focus.
  5. Innovative Drug Delivery Systems:
    The journal covers advancements in drug delivery technologies, including nanotechnology and biopolymer-based systems, aimed at enhancing therapeutic efficacy and patient compliance.
  6. Natural Products and Traditional Medicine:
    There is a consistent focus on the pharmacological properties of natural compounds and traditional medicine formulations, illustrating their roles in modern therapeutic applications.
The journal has observed notable trends and emerging themes that highlight its dynamic nature and responsiveness to contemporary issues in drug design and therapy.
  1. Network Pharmacology and Systems Biology:
    There is a growing trend towards the use of network pharmacology and systems biology approaches to understand drug interactions, mechanisms of action, and to identify therapeutic targets.
  2. Personalized Medicine:
    Research focusing on personalized or precision medicine is on the rise, reflecting a shift towards tailoring therapies based on individual patient profiles and genetic backgrounds.
  3. Integrative and Complementary Approaches:
    There is an increasing interest in the integration of traditional medicine with modern pharmacological methods, exploring the efficacy of herbal and natural products in contemporary therapeutic applications.
  4. Nanotechnology in Drug Delivery:
    The application of nanotechnology in drug delivery systems is emerging as a critical area of focus, aimed at improving bioavailability and targeting specific tissues or cells.
  5. Longitudinal and Real-World Evidence Studies:
    The journal is increasingly publishing longitudinal studies and real-world evidence research that assess the long-term efficacy and safety of treatments in diverse patient populations.
  6. Immunotherapy and Biologics:
    There is a noticeable trend towards research in immunotherapeutic agents and biologics, reflecting the growing importance of these therapies in the treatment of various diseases, particularly cancers.

Declining or Waning

While the journal continues to thrive in several research areas, some themes have shown a decline in prominence, reflecting changing priorities and advancements in the field.
  1. Conventional Pharmaceutical Approaches:
    Research focused solely on conventional pharmaceutical drugs without consideration of integrative or novel approaches appears to be waning, as the field shifts towards more innovative and holistic strategies.
  2. Single-Agent Studies:
    There is a noticeable reduction in studies that evaluate the efficacy of single-agent therapies, as combination therapies and multi-target strategies become more favorable in clinical settings.
  3. Basic Science Studies:
    Research with a purely basic science focus, lacking translational or clinical relevance, is increasingly less common, as the journal emphasizes studies with direct implications for drug development and therapy.
  4. Short-Term Efficacy Studies:
    The focus on short-term efficacy and safety studies is diminishing, with a greater emphasis now being placed on long-term outcomes and the comprehensive assessment of therapeutic regimens.

Similar Journals

ACTA PHARMACEUTICA

Empowering knowledge sharing in pharmaceutical sciences.
Publisher: SCIENDOISSN: 1330-0075Frequency: 4 issues/year

ACTA PHARMACEUTICA is a distinguished open-access journal published by SCIENDO, dedicated to advancing knowledge in the fields of medicine and pharmaceutical sciences. Established in 1992, the journal has made significant contributions to the scholarly community, providing a platform for innovative research and discussion. With a strong presence in both Q2 and Q3 quartiles across various categories including Pharmaceutical Science and Pharmacology, ACTA PHARMACEUTICA ranks favorably, positioning its contributions in the upper tiers of the field. The journal's commitment to open access since 2007 ensures that both practitioners and scholars have immediate access to cutting-edge developments, thereby fostering collaboration and knowledge sharing. With its scope spanning a broad spectrum of pharmaceutical and biomedical research, ACTA PHARMACEUTICA is an essential resource for researchers, professionals, and students keen to stay abreast of the latest advancements and trends in these vital areas of study.

Drug Discoveries and Therapeutics

Advancing drug discovery for a healthier tomorrow.
Publisher: INT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENTISSN: 1881-7831Frequency: 6 issues/year

Drug Discoveries and Therapeutics is a highly regarded journal devoted to the advancement of knowledge in the field of medicine and pharmacology. Published by the International Research & Cooperation Association for Biological & Socio-Sciences Advancement in Tokyo, Japan, this journal serves as a vital resource for researchers, practitioners, and students interested in the latest developments in drug discovery and therapeutic strategies. With a Scopus ranking of #192 out of 826 in the General Medicine category, and positioning itself in the 76th percentile, it demonstrates a significant impact within the scientific community. The journal publishes original research articles, reviews, and innovative studies that address the complexities of drug development, therapeutic efficacy, and clinical applications. Researchers and clinicians can access valuable insights to enhance their practices and inform further studies as it continues to disseminate crucial findings essential for the advancement of medical science.

DRUG DEVELOPMENT RESEARCH

Exploring the frontiers of drug discovery and development.
Publisher: WILEYISSN: 0272-4391Frequency: 8 issues/year

DRUG DEVELOPMENT RESEARCH is a premier interdisciplinary journal published by Wiley, focusing on the latest advancements in drug discovery, pharmacology, and toxicology. With an ISSN of 0272-4391 and an E-ISSN of 1098-2299, this esteemed publication has been a cornerstone in the field since its inception in 1981 and continues to provide cutting-edge research until 2024. Its rigorous peer-review process and strategic placement in Q2 of the Drug Discovery category, as well as ranking #60 out of 157 in Scopus, underscore the journal's relevance and influence, boasting a respectable 62nd percentile ranking. While the journal does not currently offer open access, it remains a vital resource for researchers, professionals, and students seeking to expand their knowledge on the processes of drug development, identifying new therapeutic targets, and assessing the efficacy and safety of novel compounds. Situated in Hoboken, NJ, this journal stands at the forefront of pharmaceutical innovation, making significant contributions to the advancement of medical science.

European Journal of Pharmacology

Elevating pharmacological knowledge for global healthcare progress.
Publisher: ELSEVIERISSN: 0014-2999Frequency: 24 issues/year

The European Journal of Pharmacology, a prestigious publication by Elsevier, serves as a vital resource in the field of pharmacology, offering rich insights into drug development and therapeutic applications. Since its inception in 1967, this journal has evolved to encompass groundbreaking research, including pharmacokinetics, toxicology, and innovative pharmacological methodologies, making it an essential platform for researchers and professionals alike. With an impressive impact factor that places it in the Q1 category of pharmacological journals and a Scopus ranking of #49 out of 313, the journal is recognized in the 84th percentile within its category, solidifying its significance in the academic community. Although the journal is not open access, it continues to attract contributions from leading scientists worldwide, ensuring that cutting-edge findings are disseminated effectively. The European Journal of Pharmacology not only highlights advancements in drug discovery and clinical applications but also promotes interdisciplinary collaboration, ultimately contributing to the progress of healthcare globally.

BIOLOGICAL & PHARMACEUTICAL BULLETIN

Bridging the Gap Between Science and Healthcare
Publisher: PHARMACEUTICAL SOC JAPANISSN: 0918-6158Frequency: 12 issues/year

BIOLOGICAL & PHARMACEUTICAL BULLETIN, published by the PHARMACEUTICAL SOC JAPAN, is a prominent peer-reviewed journal that serves the fields of medicine, pharmaceutical science, and pharmacology. With an ISSN of 0918-6158 and an E-ISSN of 1347-5215, this publication has been crucial in disseminating innovative research since its inception in 1993, and it continues to contribute significantly to the body of knowledge as it converges towards 2024. Despite being classified as a non-open access journal, it maintains a respectable Q3 ranking in Medicine (miscellaneous) and Q2 in Pharmaceutical Science, highlighting its critical role in advancing scientific discourse in these areas. With Scopus rankings placing it in the 51st percentile for Pharmaceutical Science and 38th percentile for Pharmacology, BIOLOGICAL & PHARMACEUTICAL BULLETIN is an essential resource for researchers, professionals, and students looking to stay abreast of cutting-edge developments and trends in biomedicine and drug development.

Pharmaceutical Sciences

Empowering global health through cutting-edge pharmaceutical research.
Publisher: TABRIZ UNIV MEDICAL SCIENCES, FAC PHARMACYISSN: 1735-403XFrequency: 4 issues/year

Pharmaceutical Sciences, an esteemed journal published by Tabriz University of Medical Sciences, Faculty of Pharmacy, serves as a crucial platform for the dissemination of pioneering research in the fields of pharmaceutical science, pharmacology, and toxicology. With an impact factor reflective of its substantial contribution to the scientific community, this open access journal has been accessible since 2012, ensuring that researchers, professionals, and students worldwide can engage with its rich content. Located in Iran, it has continually evolved, covering research from 2009 to 2024, and boasts impressive rankings in multiple Scopus categories, including Q3 in Pharmaceutical Science and Q2 in Pharmacology, Toxicology and Pharmaceutics. By bridging gaps between scientific inquiry and practical applications, Pharmaceutical Sciences is dedicated to advancing pharmaceutical knowledge and promoting innovative practices that address significant health challenges.

International Journal of Pharmacology

Innovating Insights in Drug Development and Safety
Publisher: ASIAN NETWORK SCIENTIFIC INFORMATION-ANSINETISSN: 1811-7775Frequency: 8 issues/year

Welcome to the International Journal of Pharmacology, a key publication in the field of pharmacology, published by ASIAN NETWORK SCIENTIFIC INFORMATION (ANSINET). Since its inception in 2006, this journal has provided a vital platform for researchers and professionals to disseminate their findings and insights in pharmacology, toxicology, and pharmaceutics. Despite recent discontinuation in Scopus coverage, the journal's dedication to fostering scientific dialogue continues to attract contributions from esteemed scholars globally. With an **ISSN of 1811-7775** and **E-ISSN of 1812-5700**, the journal seeks to bridge the gap between laboratory research and clinical application, promoting a deeper understanding of drug actions and interactions. Although it operates under traditional access options, the relevance of its published studies to ongoing pharmacological research remains significant.

Frontiers in Pharmacology

Driving excellence in pharmacological research and education.
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Pharmacology, published by FRONTIERS MEDIA SA, stands as a leading open-access journal dedicated to advancing the field of pharmacology since its inception in 2010. With its ISSN 1663-9812, the journal is based in Switzerland and maintains a vital role in disseminating innovative research findings that span various disciplines within pharmacology, including pharmacokinetics, toxicology, and pharmacogenetics. In 2023, Frontiers in Pharmacology has achieved an impressive standing within the scientific community, being ranked in the Q1 category for both general and medical pharmacology, highlighting its critical contribution to the field with a Scopus ranking of #41 out of 272 in medical pharmacology and #76 out of 313 in pharmacology, toxicology, and pharmaceutics, placing it in the 75th and 85th percentiles, respectively. Researchers and practitioners benefit from its open-access model, which ensures widespread accessibility to groundbreaking research, fostering collaboration and innovation across the pharmaceutical sciences. With its commitment to excellence, Frontiers in Pharmacology serves as an essential resource for those looking to explore and contribute to the latest advancements in pharmacological research.

DARU-Journal of Pharmaceutical Sciences

Exploring the forefront of pharmacology and toxicology.
Publisher: SPRINGER INT PUBL AGISSN: Frequency: 2 issues/year

DARU-Journal of Pharmaceutical Sciences is a leading peer-reviewed journal published by SPRINGER INT PUBL AG that focuses on the dynamic and rapidly evolving fields of pharmaceutical sciences, including drug discovery, pharmacology, and toxicology. With an impressive Q2 ranking in both Drug Discovery and Miscellaneous Medicine categories for 2023, this journal stands out as a vital resource for researchers, professionals, and students alike, offering a platform for significant contributions to the scientific community. Covering a comprehensive scope from 2000 to 2024 and indexed by Scopus, the journal ranks within the top percentile in its field, with a ranking of #66/313 in Pharmacology and #34/157 in Drug Discovery, reaffirming its impact and relevance. The journal promotes open access to foster widespread dissemination of knowledge in pharmaceutical sciences, ultimately aiming to bridge the gap between research and clinical applications. For those looking to stay at the forefront of pharmaceutical innovation, DARU represents an invaluable connection to the latest studies and breakthrough findings.

PHARMACIA

Fostering collaboration in the quest for pharmaceutical excellence.
Publisher: PENSOFT PUBLISHERSISSN: 0428-0296Frequency: 4 issues/year

PHARMACIA is a distinguished open-access journal, published by PENSOFT PUBLISHERS, that has been a pivotal platform for advancing the field of pharmaceutical sciences since 2007. This journal, with ISSN 0428-0296 and E-ISSN 2603-557X, is based in Bulgaria and continues to publish high-quality research and reviews relevant to pharmacy, pharmacology, and toxicology. Recognized in the Q3 category for Pharmaceutical Sciences and Pharmacology (medical), as well as Q2 in Pharmacy according to the latest rankings, PHARMACIA is celebrated for its commitment to fostering knowledge dissemination and innovation in drug development, therapeutic approaches, and pharmacological research. With a Scopus rank of #17 in Pharmacy and recognition in various health professions, the journal attracts contributions from researchers, professionals, and students seeking to impact the pharmaceutical landscape. Its convenient open-access format ensures that articles are readily available to a global audience, encouraging collaboration and advancement in the life sciences.